Assura Plc (LON:AGR – Get Free Report) insider Sam Barrell sold 34,153 shares of the company’s stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of GBX 48, for a total transaction of £16,393.44.
Assura Stock Performance
LON AGR opened at GBX 48.68 on Friday. The stock has a market cap of £1.59 billion, a P/E ratio of -46.53, a PEG ratio of 3.60 and a beta of 0.37. The company’s 50-day simple moving average is GBX 49.70 and its 200 day simple moving average is GBX 47.49. Assura Plc has a twelve month low of GBX 35.24 and a twelve month high of GBX 50.95. The company has a quick ratio of 2.84, a current ratio of 0.89 and a debt-to-equity ratio of 85.05.
Assura (LON:AGR – Get Free Report) last posted its earnings results on Monday, July 21st. The real estate investment trust reported GBX 3.50 earnings per share for the quarter. Assura had a negative net margin of 18.09% and a negative return on equity of 1.92%. As a group, research analysts forecast that Assura Plc will post 3.5830389 earnings per share for the current fiscal year.
About Assura
Assura plc is a specialist healthcare property investor and developer. We enable better health outcomes through our portfolio of more than 600 healthcare buildings across the UK and Ireland, from which over six million patients are served.
We BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G).
Assura plc achieved B Corp certification in July 2024 – the first FTSE 250 business to do so.
Featured Stories
- Five stocks we like better than Assura
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Equal Weight ETFs: Hidden Upside in Today’s Market
- How to Plot Fibonacci Price Inflection Levels
- Zillow Group Approaching Key Technical Levels: Is It Time to Buy?
- How to Short a Stock in 5 Easy Steps
- For True Diversification: 3 Stocks You Can Buy Now
Receive News & Ratings for Assura Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assura and related companies with MarketBeat.com's FREE daily email newsletter.